Fulcrum Therapeutics (FULC)
NASDAQ:FULC
Want to see FULC full AI Analyst Report?
FULC Analyst Ratings
Hold
2 Buy
5 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FULC Stock 12 Month Forecast
Average Price Target
$7.00
▼(-15.56% Downside)
| Highest Price Target$24.00 | Average Price Target$7.00 | Lowest Price Target$3.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leerink Partners
$24→$4
Hold
-51.75%
Downside
Downgraded
06/02/26
H.C. Wainwright
$25→$3
Hold
-63.81%
Downside
Downgraded
06/02/26
J.P. Morgan
―
Sell
―
Downgraded
06/02/26
Truist Financial
$17→$4
Hold
-51.75%
Downside
Downgraded
06/02/26
Bank of America Securities
$8→$3
Sell
-63.81%
Downside
Reiterated
06/02/26
Piper Sandler
$23→$3
Sell
-63.81%
Downside
Downgraded
06/02/26
Stifel Nicolaus
$25→$3
Hold
-63.81%
Downside
Downgraded
06/02/26
RBC Capital
$10→$4
Hold
-51.75%
Downside
Reiterated
06/02/26
Oppenheimer
$15
Buy
80.94%
Upside
Reiterated
04/28/26
Cantor Fitzgerald
$24
Buy
189.51%
Upside
Reiterated
03/19/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
$24→$4
Hold
-51.75%
Downside
Downgraded
06/02/26
H.C. Wainwright
$25→$3
Hold
-63.81%
Downside
Downgraded
06/02/26
J.P. Morgan
―
Sell
―
Downgraded
06/02/26
Truist Financial
$17→$4
Hold
-51.75%
Downside
Downgraded
06/02/26
Bank of America Securities
$8→$3
Sell
-63.81%
Downside
Reiterated
06/02/26
Piper Sandler
$23→$3
Sell
-63.81%
Downside
Downgraded
06/02/26
Stifel Nicolaus
$25→$3
Hold
-63.81%
Downside
Downgraded
06/02/26
RBC Capital
$10→$4
Hold
-51.75%
Downside
Reiterated
06/02/26
Oppenheimer
$15
Buy
80.94%
Upside
Reiterated
04/28/26
Cantor Fitzgerald
$24
Buy
189.51%
Upside
Reiterated
03/19/26
Best Analysts Covering Fulcrum Therapeutics
3 Months
Success Rate
10/19 ratings generated profit
Average Return
+1.68%
Copying Matthew Biegler's trades and holding each position for 3 Months would result in 52.63% of your transactions generating a profit, with an average return of +1.68% per trade.
1 Year
Success Rate
7/12 ratings generated profit
Average Return
+5.19%
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +5.19% per trade.
2 Years
Success Rate
9/12 ratings generated profit
Average Return
+30.78%
Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +30.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FULC Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
11
8
10
6
4
Buy
8
3
1
0
0
Hold
2
1
2
1
6
Sell
4
3
1
1
4
Strong Sell
0
0
0
0
0
total
25
15
14
8
14
Each month's total comprises the sum of three months' worth of ratings.
FULC Financial Forecast
FULC Stock Forecast FAQ
What is FULC’s average 12-month price target, according to analysts?
Based on analyst ratings, Fulcrum Therapeutics’s 12-month average price target is 7.00.
What is FULC’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for FULC, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FULC a Buy, Sell or Hold?
Fulcrum Therapeutics has a consensus rating of Hold which is based on 2 buy ratings, 5 hold ratings and 3 sell ratings.
What is Fulcrum Therapeutics’s price target?
The average price target for Fulcrum Therapeutics is 7.00. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $24.00 ,the lowest forecast is $3.00. The average price target represents -15.56% Decrease from the current price of $8.29.
The highest analyst price target is $24.00 ,the lowest forecast is $3.00. The average price target represents -15.56% Decrease from the current price of $8.29.
What do analysts say about Fulcrum Therapeutics?
Fulcrum Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of FULC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.